Acrivon Therapeutics, Inc. (ACRV): SC 13G filed Nov 25, 2022

Form type

SC 13G

Filing date

Nov 25, 2022

Accession number

0001193125-22-292633

Filer

Acrivon Therapeutics, Inc. (CIK 1781174)